Results 141 to 150 of about 15,560 (165)
Progressive Supranuclear Palsy [PDF]
Archives of Neurology, 1982 To the Editor.— I appreciated the letter to the editor "Progressive Supranuclear Palsy Despite Normal Eye Movements" by Dr Nuwer (Archives1981;38:784). In the case reported by Dr Nuwer, the diagnosis was supported by electronystagmography, which showed typical changes, and pneumoencephalography, which demonstrated pontine and midbrain atrophy ...
Francis J. Pirozzolo +2 more
+11 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Progressive supranuclear palsy
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2021Progressive supranuclear palsy (PSP) is a heterogeneous progressive neurodegenerative disease characterized by onset after 50 years old, Parkinson's syndrome, early development of postural instability, absence or transient reaction to levodopa drugs, neuropsychological disorders, dysphagia and dysarthria and eye movement disorders.
A D Mikhaylova +3 more
openaire +2 more sources
Progressive Supranuclear Palsy
Science of Aging Knowledge Environment, 2004In this case study, we describe the symptoms, neurological examination, clinical course, and neuropathology of a patient with progressive supranuclear palsy (PSP). PSP is a relatively uncommon neurodegenerative disorder with many features similar to those of Parkinson's disease .
Jean-Paul Vonsattel, Michael H. Pourfar
openaire +3 more sources
Progressive Supranuclear Palsy [PDF]
, 2005 Progressive supranuclear palsy (PSP) is the most common atypical neurodegenerative parkinsonian disorder (1,2). It was first described as a discrete clinicopathological entity by Steele et al. (3) in 1964 (Fig. 1), but there are several previous clinical descriptions of patients who may have had this disease (see Chapter 2).
Irene Litvan, Andrew J. Lees
openaire +2 more sources
Progressive supranuclear palsy
2019Progressive supranuclear palsy (PSP) is a neurodegenerative disease characterized pathologically by 4 repeat tau deposition in various cell types and anatomical regions. Richardson's syndrome (RS) is the initially described and one of the clinical phenotypes associated with PSP pathology, characterized by vertical supranuclear gaze paly in particular ...
Giagkou, Nikolaos +2 more
openaire +4 more sources
Progressive supranuclear palsy
2007![Graphic][1] A typical PSP patient. Note the marked reduction in facial expression and frontalis overactivity. Progressive supranuclear palsy (PSP) is a neurodegenerative disease, classified pathologically as a tauopathy, which all neurologists encounter from time to time.
Burn D, Lees A
openaire +5 more sources
PROGRESSIVE SUPRANUCLEAR PALSY
Age and Ageing, 1977In the past four years, four patients with progressive supranuclear palsy have presented to the Department of Geriatric Medicine, Oxford, under the care of one of us (RAG). They were all females whose symptoms began in the sixth or seventh decade. They died from three to six years after the onset of symptoms. All had neuropathological studies which are
J. A. Dalziel, R. A. Griffiths
openaire +3 more sources
PROGRESSIVE SUPRANUCLEAR PALSY
Medical Clinics of North America, 1999Richardson observed an unusual clinical syndrome in the 1950s, which he later designated progressive supranuclear palsy (PSP). Over the past 25 years, although knowledge of this disorder has gradually improved, its cause is still unknown, pathogenesis is unclear, and there is still no definitive treatment for this disorder.
openaire +5 more sources
Progressive supranuclear palsy
Nursing Standard, 2013Progressive supranuclear palsy (PSP), or Steele-Richardson-Olszewski syndrome, is a rare, progressive neurodegenerative condition with cognitive and motor involvement. Diagnosis can be challenging as some people do not display the classic symptoms of the condition and there are no specific investigations to confirm diagnosis.
openaire +3 more sources
Hyposmia in progressive supranuclear palsy
Movement Disorders, 2010AbstractPrevious studies suggested that olfaction is normal in progressive supranuclear palsy (PSP). We applied the University of Pennsylvania Smell Identification Test (UPSIT) to 36 patients with PSP who scored more than 18 on the Mini Mental State Examination (MMSE), 140 patients with nondemented Parkinson's disease (PD) and 126 controls.
Aviva Petrie +12 more
openaire +3 more sources